Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Xi'an Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturer and a subsidiary of the Xi'an Lijun Pharmaceutical Group. Based in the Dadukou District of Chongqing, the company specializes in the production of chemical active pharmaceutical ingredients (APIs) and finished dosage forms, including large and small volume injections and oral medications. Its core product portfolio is centered on anti-infective agents, such as oxytetracycline and lincomycin, as well as essential vitamins and cardiovascular treatments. The company operates GMP-certified facilities and serves as a strategic manufacturing hub for its parent organization, supplying both the domestic Chinese market and international clients. Chongqing Xi'an Pharmaceutical is recognized for its long-standing expertise in chemical synthesis and large-scale pharmaceutical production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Xi'an Pharmaceutical.